NCT00419003View on ClinicalTrials.gov

Research Study for Major Depressive Disorder: Investigation of Glutamate Medications

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

September 30, 2008

Conditions
Major Depression
Interventions
DRUG

Lamotrigine

anticonvulsant medication

DRUG

Ketamine

subanesthetic dose of NMDAR antagonist

DRUG

Riluzole

glutamate release inhibitor

Trial Locations (1)

10029

Mount Sinai School of Medicine, New York

All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

collaborator

National Center for Research Resources (NCRR)

NIH

lead

Baylor College of Medicine

OTHER

NCT00419003 - Research Study for Major Depressive Disorder: Investigation of Glutamate Medications | Biotech Hunter | Biotech Hunter